ABD PAD
- Risk class
- IV
- Product type
- In Vitro Diagnostic
- Brand name
- DIAGAST
- Commercial name
- 19-294 IVD Reagents/Kits, Immunohematology, Blood Pooling
- Analysis ID
- ef4f5c35fb7dd28694ed7b0df17e87a7
- Registration date
- December 07, 2022
- Expiration date
- December 07, 2027
- Name
- DIAGAST
- City
- LOOS
- Country
- FRENCH
- Address
- 251 AVENUE EUGENE AVINNEE, 59120 LOOS- FRANCE
- Name
- DIAGAST
- Country
- FRENCH
- Address
- BARRIO JIPIJAPA STREET: ISLA FERNANDINA NO. N42-40 INTERSECCION ISLA TORTUGA
- Phone
- 2252800
ALLOWS THE CONTROL OF THE BLOOD GROUP ABO / RH (CONFIRMATION OR CONTROL PRE-DONATION), BY DETERMINING THE PRESENCE OF ERYTHROCYTE ANTIGENS A, B AND D ON THE SURFACE OF THE HUMAN HEMATIES.
Access comprehensive regulatory information for ABD PAD in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID ef4f5c35fb7dd28694ed7b0df17e87a7 and manufactured by DIAGAST. The device was registered on December 07, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.